Introduction
The exocrine pancreas secretes digestive enzymes, fluid, and bicarbonate in response to food ingestion. This is a critical digestive process that is regulated by neural reflexes, gastrointestinal hormones, and absorbed nutrients. Secretion is highly regulated by both stimulatory and inhibitory influences that coordinate the delivery of digestive enzymes with food emptying into the intestine to assure adequate digestion of a meal. In the absence of proper pancreatic secretion, maldigestion and malabsorption of nutrients may cause malnutrition and associated complications. This review describes the physiological processes that regulate pancreatic exocrine secretion.
Phases of Meal Response
Pancreatic secretion in response to a meal occurs in four distinct but overlapping phases which are named based on the location of ingested food. The four phases of pancreatic secretion are cephalic, gastric, intestinal, and absorbed nutrient. Considerable crosstalk and inter-regulation is associated within the phases, thereby ensuring adequate, but not excessive, enzyme and bicarbonate secretion. Each phase is regulated by a complex network of neural, humoral, and paracrine feedback mechanisms which help to maintain an optimal environment for food digestion and absorption.
Cephalic Phase
Sensory inputs such as sight, smell, taste, and mastication (prior to swallowing) lead to the anticipation of food. These sensations initiate the first phase of pancreatic secretion known as the cephalic phase. In addition to sensory input, interaction of certain food molecules such as long chain fatty acids (but not triglycerides or medium chain fatty acids) with receptors in the oral cavity also induce the cephalic phase (119) . Furthermore, studies in animals have implicated a gustatory vago-pancreatic reflex in mediating the cephalic phase of pancreatic secretion (247, 271) .
Approximately 20-25% of the total pancreatic exocrine secretion occurs during the cephalic phase (8, 54, 163) . This estimate is based on data obtained by sham feeding, a process by which food is anticipated by sight, smell, and taste, but not ingested. Sham feeding in animals such as dogs, has been evaluated by inserting a surgically prepared gastric fistula that diverts food from the esophagus, allowing swallowing but not entry of food into the stomach. In humans sham feeding involves chewing but not swallowing. The pancreatic response to sham feeding in humans lasts approximately 60 minutes while in dogs it can last for more than 4 hours (288, 302) . Sham feeding stimulates pancreatic secretion which is low in bicarbonate but rich in enzymes, suggesting that pancreatic acinar, rather than ductal cells are stimulated in this phase (8) .
The cephalic phase of exocrine secretion is under the control of the vagus nerve. Sensory inputs arising from anticipation of food are integrated in the dorsal vagal complex (located in the brainstem) and transmitted to the exocrine pancreas via the vagus nerve (83, 256) . Cholinergic agonists produce secretory responses similar to cephalic stimulation while vagotomy blocks the cephalic responses, suggesting that acetylcholine released by vagal efferents is the primary mechanism by which sensory inputs lead to exocrine secretion (18, 125) . Secretion of the islet hormone, pancreatic polypeptide (PP), increases with sham feeding and serves as an indicator of vagal innervation of the pancreas, as its secretion is inhibited by cholinergic blockers (149, 293) . When sham feeding is accompanied by swallowing, the pancreatic secretory and PP responses are much greater implying that chewing and swallowing stimulate PP secretion by cholinergic mechanisms (294) .
The exocrine pancreas contains peptidergic nerve terminals and there is some evidence to suggest that neuropeptides such as vasoactive intestinal peptide (VIP) and gastrin-releasing peptide (GRP) may influence the cephalic phase. In addition, thyrotropin-releasing hormone stimulates pancreatic exocrine secretion of protein and bicarbonate through vagal efferents and this process involves both muscarinic and VIP receptors (8, 121, 160) . In contrast, the effects of inhibitory cerebral calcitonin gene-related peptide (CGRP) are mediated by sympathetic noradrenergic efferents acting upon α-adrenergic receptors (160, 211) . Sham feeding and electrical vagus nerve stimulation in dogs triggers the release of cholecystokinin (CCK) although this response may be absent in humans (8, 155, 291) . Endogenous CCK was shown to enhance PP release in humans during sham feeding (149) . Therefore, although peptidergic neurotransmitters are released during vagal stimulation, acetylcholine is believed to be the main neurotransmitter which regulates the cephalic phase.
A number of G protein-coupled receptors (GPCRs) located on acinar cells also mediate the cephalic phase of enzyme secretion. Interaction of CCK with CCK-1 receptors has been shown to induce protein secretion in new born calves (352) . This response is possibly dependent upon neural CCK release as cephalic stimulation does not increase blood levels of CCK. Thus, both neural and hormonal mechanisms play an important role in regulating the cephalic phase of pancreatic secretion.
Gastric Phase
Entry of food into the stomach initiates the gastric phase of pancreatic secretion. This phase has been difficult to study in unanesthetized animals because presence of food in the stomach initiates neural reflexes and release of hormones. Therefore, physiological data regarding this phase has been collected by gastric distention induced either by balloon dilation or instillation of inert substances in the antrum.
Experiments in which gastric contents were prevented from emptying into the duodenum demonstrated that the gastric phase accounted for approximately 10% of pancreatic secretion. Secretions induced during this phase consist mainly of enzymes with minimal release of bicarbonate suggesting that acinar cells are primarily involved in the induction of this phase (8, 37, 331, 338) .
The role of gastrin in this phase of pancreatic secretion remains unclear. It was demonstrated that step-wise alkaline distension of the antrum induced graded release of gastrin and pancreatic enzymes (53). However, when exogenous gastrin was administered to dogs the amount required to stimulate exocrine secretion was much greater than normal postprandial gastrin levels, suggesting that gastrin did not have a physiological role (160) . These findings are supported by other studies demonstrating that gastrin release is not required for pancreatic enzyme secretion during this phase.
The vagus nerve plays an important role in the gastric phase of pancreatic secretion. Early experiments in anesthetized cats demonstrated that stimulation of the antrum resulted in vagal stimulation of pancreatic amylase release (25) . Antral distension in dogs also increased pancreatic secretion by long route vagal pathways (53). An antropancreatic short reflex pathway which is blocked by hexamethonium and atropine also mediates this phase (82) . In addition, atropine and vagotomy block the gastric phase providing further evidence that gastric contributions to pancreatic secretion are mediated by vagovagal cholinergic reflexes that originate in the stomach and terminate in the pancreas (173, 338, 339) . CCK release plays an important role in antral motility and gastrin release in humans as suggested by sham feeding experiments (149) .
In the stomach, pepsin and gastric lipases catabolize proteins and fats into peptides and triglycerides plus fatty acids, respectively, while salivary amylase contributes to the continued digestion of carbohydrates. Peptic digests of proteins are effective in stimulating the intestinal phase (100). Thus when gastric chyme enters the duodenum, it stimulates the intestinal phase of pancreatic secretion. In a clinical setting, surgical procedures that slow the rate of gastric emptying reduce pancreatic secretion (200, 207) . Therefore, the rate of gastric emptying regulates the discharge of nutrients into the intestine and consequently the activation of the intestinal phase through neural and hormonal pathways.s
Intestinal Phase
As mentioned above, digestion of food in the stomach is followed by release of acidic chyme into the duodenum which initiates the intestinal phase of pancreatic secretion. By this phase, the pancreas has already been primed by cephalic and gastric influences, which enhance blood flow and initiate exocrine secretion. A majority of the pancreatic secretory response (50 -80%) occurs during the intestinal phase and is regulated by hormonal and neural mechanisms.
The intestinal phase is more easily studied than the gastric phase as food can be instilled directly into the intestinal lumen without concern for gastric emptying. Stimulation of both acinar and ductal cells results in the production of enzyme and bicarbonate secretion. Pancreatic amylase secretion is stimulated by food molecules such as sodium oleate, monoglycerides, peptides, and amino acids (particularly tryptophan and phenylalanine) (50, 88, 188, (215) (216) (217) . In the duodenum the high volume of bicarbonate released neutralizes the acidity of gastric chyme, while pancreatic enzymes catabolize partially digested food into molecules that are easily absorbed by intestinal enterocytes.
In the intestinal phase, pancreatic response is regulated primarily by the hormones secretin and CCK, and by neural influences including the enteropancreatic reflex which is mediated by the enteric nervous system and amplifies the pancreatic secretory response. Entry of low pH gastric chyme into the intestine stimulates release of secretin from S cells into the blood (164) . The main action of secretin is to stimulate bicarbonate release from pancreatic duct cells, but it also has a direct effect on acinar cells and potentiates enzyme secretion. The role of secretin in pancreatic secretion is addressed later in this review. CCK is released by proteins and fats and their partial digestion products: peptides and fatty acids. Experiments in dogs with chronic pancreatic fistulae have shown that CCK antagonism diminishes pancreatic protein response to a meal and duodenal perfusion suggesting that CCK plays an important role in this phase (169) . Similar results were also obtained in humans, where CCK receptor antagonism reduced pancreatic enzyme secretion during the intestinal phase (85, 116) . Cholinergic regulation plays a critical role during this phase of pancreatic secretion. In the absence of secretin, atropine partially inhibits pancreatic bicarbonate secretion stimulated by low pH due to acidic chyme in the duodenum (306, 349) . In addition, the amount of bicarbonate produced by infusion of secretin is lower than that released by entry of food into the duodenum suggesting that other factors contribute to meal-stimulated pancreatic bicarbonate secretion (30) . Atropine inhibited pancreatic enzyme secretion from 30 -120 minutes following meal ingestion, implicating cholinergic mechanisms (30) . Vagovagal enteropancreatic reflexes mediated by M1 and M3 muscarinic receptors and CCK receptors play an important role in the intestinal phase of secretion (302, 304) . These vagovagal enteropancreatic reflexes are modulated by input from the dorsal motor nucleus of the vagus projecting into the pancreas. Thus, vagal stimulation activates pancreatic bicarbonate secretion through both cholinergic muscarinic and noncholinergic transmission.
Role of Gastric Acid
The physiological effects of acid on pancreatic secretion have been evaluated by various methods such as diversion of gastric and pancreatic contents with fistulae, and instillation of acidic solutions into the duodenum. Both gastric acid and exogenous HCl are powerful regulators of postprandial pancreatic bicarbonate secretion and their effects are potentiated by intrapancreatic and vagovagal neural pathways as well as by hormones such as secretin and CCK (303) indicating that the physiological effects of gastric acid are due to its pH.
Intraduodenal infusion of hydrochloric acid elicited a concentration-dependent increase in both the amount of bicarbonate and volume of pancreatic secretion. Secretion was similar to that attained with intravenous infusion of exogenous secretin suggesting that pH changes resulting from entry of acidic contents into the duodenum are important in inducing pancreatic secretion. Administration of a peptone meal of varying pH (pH 1 to 5) produced a maximal secretory response at pH 3.0, which was comparable in magnitude to that obtained with exogenous secretin (58). Acid infusion in both the duodenum and upper jejunum elicited pancreatic secretion suggesting that the proximal small intestine responds to this stimulus (164) .
Entry of gastric contents into the duodenum creates an acidic environment with a pH of 2.0 -3.0 in the initial segment of the duodenum, while the pH of the distal segment remains alkaline (32, 279) . This difference in pH is due to pancreatic bicarbonate release, which is augmented in large part by gastric acid-induced secretin release from the intestinal mucosa. In conscious rats with gastric and pancreatic fistulae, diversion through a gastric fistula produced a small increase in pancreatic secretion. However, instilling hydrochloric acid into the duodenum with an open gastric fistula augmented pancreatic secretion (22, 94) . In addition, pancreatic bicarbonate secretion was much greater when pancreatic juice was diverted from the intestine signifying a correlation between intestinal pH and quantity of pancreatic bicarbonate release (48, 113) .
The pancreatic bicarbonate response is dependent on the concentration of free unbuffered hydrogen ions and not on the total load of buffered acid entering the duodenum. Inhibition of gastric acid production by cimetidine (an histamine H2 receptor blocker) or omeprazole (an H + /K + ATPase inhibitor) substantially reduced the pancreatic bicarbonate response to a meal (22, 232) . The pH of a liquid gastric meal also plays a significant role in pancreatic bicarbonate secretion; in cats and dogs, pH > 4.5 resulted in little pancreatic bicarbonate secretion, while at pH <4.0 secretion increased substantially suggesting that a pH threshold of < 4.5 is critical for stimulation of pancreatic secretion (58, 219).
This evidence implies that gastric acid is an important regulator of pancreatic bicarbonate secretion which neutralizes the acid to create an alkaline environment optimal for the action of pancreatic enzymes and continued digestion of food.
Role of Dietary Fat in Pancreatic Secretion
Dietary fats stimulate pancreatic enzyme and bicarbonate secretion. Perfusion of monoolein stimulated pancreatic enzyme secretion in humans and this effect was similar in potency to that observed with intravenous CCK injection (202) . In contrast, triglycerides administered directly into the duodenum (in the absence of endogenous lipase) were unable to induce pancreatic secretion. However, following lipase digestion of fatty acids, monoglycerides stimulated pancreatic secretion but glycerol was ineffective indicating that fatty acids are the major component of ingested fats that stimulate pancreatic secretion (202, 214) .
There is some evidence to suggest that both free and saponified fatty acids induce pancreatic secretion, while other experiments suggest effectiveness only in a micellar form. Secretion has been shown to be dependent on fatty acid chain length, with C4 being least effective and C18 being most effective (59). Although the reason for this difference in potency is not entirely clear, it is not believed to be related to the efficiency of absorption (201) . Other studies have demonstrated that intraduodenal administration of propionate (C3) was more effective than oleate (C18) in stimulating acinar cell secretion (241) . The reason for the differences between the two studies is not entirely clear but could be species related as these experiments have been performed in humans, rats, and rabbits. Both oleate and neutral fats stimulate bicarbonate and fluid secretion, whereas only neutral fats stimulate pancreatic enzyme secretion. In dogs, oleic acid was shown to potentiate acidified proteinmeditated pancreatic enzyme and bicarbonate secretion (75) . Fat emulsions given to conscious rats produced a 3-fold increase in pancreatic protein secretion. The route of fat administration also has an impact on pancreatic secretion. Intravenous administration of fat did not produce pancreatic secretion, whereas intraduodenal administration led to elevated protein, bicarbonate, and fluid secretion (246, 315) .
Administration of fat emulsions increases plasma CCK and secretin levels. Fat-mediated pancreatic secretion was blocked by proglumide, a CCK receptor antagonist, implicating the importance of CCK in stimulating pancreatic secretion (97) . Both C12 and C18 fatty acids augment the effects of secretin-induced bicarbonate secretion (74) . In humans, introduction of different concentrations of oleic acid into the duodenum induce pancreatic secretion, although the threshold for CCK stimulation is much lower than for secretin (252) . Secretin release is physiologically important since injection of anti-secretin antibodies in conscious rats greatly reduce fat-mediated protein and bicarbonate secretion (101) .
A critical fatty acid chain length of C12 was required for CCK release from STC-1 cells, a neuroendocrine tumor cell line. Fatty acids with less than ten carbon atoms did not augment secretion. This dependence on fatty acid chain length is similar to that observed previously for in vivo CCK release in humans. In addition to the fatty acid carbon chain length, a free carboxyl terminus is also important as esterification of the carboxylic terminus abolished CCK secretion, while modification of the methyl terminus had no effect (208) (209) (210) . Two cell surface receptors have been identified and demonstrated to promote fatmediated CCK release. Mice with global deletion of GPR40 show partial reduction in CCK secretion following fatty acid administration (193) . The recently discovered immunoglobulin-like domain containing receptor (ILDR) is expressed in I cells of the duodenum. ILDR appears to play an essential role in fat-stimulated CCK release as deletion of ILDR in mice completely eliminates fatty acid-stimulated CCK secretion (39) . Thus fats and fatty acids are important regulators of pancreatic secretion. Experimental evidence suggests that the degree and extent of acinar and ductal cell activation may vary depending on the animal species and the route of fat administration.
Contributions of Proteins, Peptides and Amino Acids to Pancreatic Secretion
Studies performed in dogs, rats, and humans have shown that proteins, peptides, and amino acids stimulate pancreatic secretion while the magnitude of this effect may be dependent on the species being evaluated (311) . In dogs, intact, undigested proteins such as casein, albumin, and gelatin did not stimulate pancreatic secretion, whereas protease digests of these proteins were very effective (215) . In contrast, studies in rats suggested that intestinal administration of hydrolyzed casein produced a smaller response than some of the other proteins which potently stimulated pancreatic enzyme secretion, suggesting that the amino acid composition of a protein is relevant in determining the extent of stimulation (96, 189) .
Although intravenous infusion of amino acids in humans stimulated pancreatic enzyme and bicarbonate secretion, a mixture of L-amino acids when infused intravenously in dogs was not effective. In contrast to intravenous infusion, intraduodenal delivery of amino acids in dogs induced pancreatic fluid, bicarbonate and protein secretion which was comparable to an elemental diet suggesting the importance of the route of administration on pancreatic secretion (315, 344) . Only L-amino acids stimulate pancreatic secretion which is consistent with the overall physiological importance of these stereoisomers. Of all the amino acids, aromatic amino acids such as phenylalanine and tryptophan have the greatest potency (76, 213, 217) .
Although aromatic amino acids are highly effective in stimulating pancreatic secretion, peptides may be more physiologically relevant as they are more abundant than amino acids in the intestinal lumen (46) . Oligopeptides and longer peptides containing the amino acids phenylalanine and tryptophan are effective stimulants of pancreatic secretion (215, 216) . Acidification of amino acid (166, 213) and peptide (76) preparations with hydrochloric acid potentiates the bicarbonate response but pancreatic enzyme secretion is not influenced beyond that observed in the absence of acid. Aromatic amino acids are capable of inducing maximal secretory response as potentiation of pancreatic enzyme secretion is not observed when amino acids or peptides are administered concomitantly with lipid molecules such as oleate or monoolein (75, 202) .
The pancreatic secretory response to intraduodenal administration of amino acids appears to be concentration dependent. A minimal concentration of 8 mM is necessary for stimulation by most amino acids (217) although the more potent aromatic amino acids such as tryptophan stimulate secretion at concentrations as low as 3 mM (305) . The length of the intestine exposed to amino acids also plays a critical role in pancreatic secretion. In dogs, exposure of the first 10 cm was least effective, while perfusion of the whole intestine produced significant enzyme output (217) suggesting that the pancreatic response was dependent upon the entire load of nutrients, not just their concentration. The majority of stimuli responsible for pancreatic stimulation originate in the proximal small intestine. In humans, amino acids stimulated pancreatic secretion only when perfused into the duodenum and no response was observed upon perfusion in the ileum (63). Therefore, similar to fats, the primary mechanisms that stimulate pancreatic secretion are limited to the proximal regions of the small intestine.
The amount of bicarbonate released by intraluminal administration of tryptophan is similar to that produced by maximal doses of exogenously infused CCK indicating that release of CCK by tryptophan leads to pancreatic secretion (52, 202, 215) . Similarly, intraduodenal administration of liver extracts in dogs mediated CCK release along with pancreatic enzyme and bicarbonate secretion, both of which were blocked by CCK receptor antagonists (234) . Bile acids released from the gallbladder can significantly inhibit pancreatic stimulation induced by intraluminal amino acids. This inhibition of pancreatic secretion by bile acids appears to be due to inhibition of CCK release and serves as a feedback mechanism in regulating pancreatic and gallbladder function (202) . By using a sensitive bioassay for CCK measurement, it was shown that one of the pathways by which proteins stimulate CCK release is by their ability to inhibit intraluminal trypsin activity (189) . Another mechanism by which aromatic amino acids mediate CCK release is by activation of the calcium sensing receptor (CaSR), a known nutrient sensor (117, 194, 240, 336) . In addition to stimulating the release of hormones such as CCK and secretin, amino acids also activate cholinergic neural mechanisms which regulate pancreatic bicarbonate secretion (305) .
Hence proteins, peptides, and amino acids stimulate pancreatic secretion but the magnitude of stimulation depends upon the mode of administration and the species being evaluated.
Role of Bile and Bile Acids in Pancreatic Secretion
Bile is produced by hepatocytes as a complex mixture of bile acids, cholesterol, and organic molecules. It is stored and concentrated in the gall bladder and released into the duodenum upon entry of chyme. Bile acids such as cholate, deoxycholate, and chenodeoxycholate are conjugated with glycine or taurine amino acids which increase their solubility. In the intestine, bile acids assist in the emulsification and absorption of fatty acids, monoacylglycerols, and lipids and stimulate lipolysis by facilitating binding of pancreatic lipase with its co-lipase.
Under basal conditions, intraduodenal administration of physiological concentrations of bile or the bile salt sodium taurocholate, elevated plasma secretin and stimulated pancreatic fluid secretion in cats (104, 105) . Secretin was released only in response to perfusion of sodium taurocholate in the duodenum. Perfusion in the upper jejunum produced a significantly diminished pancreatic response, while no response was observed upon ileal perfusion (107) . Pancreatic fluid secretion was stimulated by the free ionized form of taurocholate and was not dependent on its detergent properties (98) . In humans, infusion of bovine bile augmented secretin release along with pancreatic exocrine secretions of fluid, bicarbonate, and enzymes (253, 254) .
In addition to secretin, infusion of bovine bile and bile acids in humans and dogs was shown to stimulate the release several hormones and neuropeptides such as CCK, neurotensin, VIP, gastric inhibitory peptide (GIP), PP, and somatostatin (34, 42, 274, 276) . Fluid and bicarbonate release was enhanced when elevated levels of VIP were present in the plasma, suggesting that bile activates peptidergic nerves resulting in pancreatic secretion. Additionally, cholinergic mechanisms are also important as atropine blocked bile-and taurocholate-stimulated exocrine pancreatic secretion (276) . The composition of bile is important in mechanisms regulating this secretory response as some differences in hydrokinetic and ecbolic responses were observed with administration of bile versus various bile acids (273).
However, a stimulatory effect of bile acids on pancreatic fluid secretion was not observed in the presence of digestive intraluminal contents (27) . In some studies where bile acids were administered concomitantly with amino acids or fat, an inhibition of pancreatic enzyme secretion was observed. The mechanism underlying this observation is not completely understood, although it is possible that bile acids inhibit CCK release by a negative feedback mechanism which helps to relax and refill the gallbladder (24, 171, 202, 248) . Chemical sequestration of bile acids in dogs augmented the release of CCK and pancreatic enzyme secretion in response to amino acids and addition of taurocholate reversed this effect (89) . Long term diversion of bile in dogs also augmented basal and oleate-stimulated pancreatic fluid, bicarbonate, and enzyme secretion along with plasma CCK levels, further supporting the role of bile acids in inhibiting CCK release (319) .
Other studies have shown that the bile salt chenodeoxycholate when infused in humans, inhibited bombesinand CCK-stimulated gallbladder emptying along with elevation of plasma CCK levels. These results led the authors to hypothesize that chenodeoxycholate, by a yet unknown mechanism, reduced the sensitivity of the gall bladder to stimulation by bombesin and CCK (326) .
In contrast to many species including mice and humans, rats do not possess a gallbladder and multiple pancreatic ducts join the lower end of the common bile duct. In rats, diversion of bile and pancreatic juice stimulates the release of pancreatic enzymes. This augmentation of enzyme secretion has been suggested to compensate for the increased degradation of proteolytic enzymes in the absence of bile. Thus exocrine secretion in rats is regulated by a luminal feedback mechanism (93, 225) . Additional experiments have shown that certain bile salts stimulate bicarbonate secretion via CCK release whereas other bile salts inhibit exocrine secretion (223, 226, 227) . Two inhibitory mechanisms have been proposed -one dependent on the stabilization of luminal proteases and the other independent of protease activity (228) . Stimulation of pancreatic fluid secretion in anesthetized rats has been demonstrated to be mediated by taurocholate induced transcription of Na
cotransporter, which plays a key role in regulating the entry of Cl -from the basolateral surface of acinar cells.
The physiological role of bile and bile salts in regulating pancreatic secretions is not completely understood and appears to be dependent on multiple factors, including the chemical properties of bile salts, the animal model being evaluated, and prandial status of the animal being studied (275) .
Absorbed Nutrient Phase
Once nutrients are absorbed from the intestinal lumen, they may directly stimulate pancreatic secretion leading to the absorbed nutrient phase. Nutrients can either directly stimulate pancreatic acinar cells, or they may indirectly activate hormonal and neural pathways to further regulate exocrine secretion. Little conclusive evidence is available for intravenous lipids and glucose in stimulating pancreatic secretion (187) . However, intravenous administration of amino acids increases the amount of trypsin and chymotrypsin secretion, but not lipase or amylase (88). Amino acids appear to have a substantial indirect effect on pancreatic secretion, since intraduodenal administration of amino acids produces large increases in pancreatic secretion (168, 218, 278) . The role of nutrients after absorption on pancreatic secretion is not well understood and additional studies are needed to fully investigate these effects. One effect is to stimulate synthesis of new digestive enzymes to replenish the pancreatic supply.
Feedback Regulation of Pancreatic Secretion
The concept of feedback regulation of pancreatic secretion emanated from a series of studies demonstrating that (1) instillation of trypsin inhibitor into the upper small intestine or (2) surgical diversion of the bile-pancreatic duct removing bile and pancreatic juice from the duodenum of rats stimulated pancreatic enzyme secretion (95) . Conversely, infusion of trypsin into the duodenum during bile-pancreatic juice diversion suppressed pancreatic enzyme release. Thus, the protease concentration in the upper small intestine appears to be intimately linked to pancreatic secretion through a negative feedback system in which active proteases within the duodenum limit pancreatic secretion but reduced protease activity stimulates pancreatic secretion. When assays for CCK became available, it was shown that CCK mediated the effects of proteases on pancreatic secretion (186) through protease-sensitive CCK releasing factors (115, 314) (see Figure 1) . In the absence of proteases, CCK releasing factor can stimulate CCK cells, but in the presence of proteases, the releasing factors are inactivated and CCK secretion is low. Negative feedback regulation of pancreatic secretion has been shown to exist in many species although other proteases such as elastase may be more important in regulating pancreatic secretion in humans. Pancreatic exocrine secretion is also influenced through a positive feedback mechanism. Monitor peptide is a 61 amino acid peptide produced by pancreatic acinar cells and possessing CCK releasing activity. Although monitor peptide has modest trypsin inhibitor capability, its ability to stimulate CCK is independent of this action because monitor peptide can directly stimulate CCK secretion from isolated CCK cells in vitro (28, 190) .
Monitor peptide is secreted in pancreatic juice, therefore, it does not stimulate CCK secretion unless pancreatic secretion is underway. Thus, monitor peptide cannot account for the increase in CCK in during bile-pancreatic juice diversion, but it may serve to reinforce pancreatic secretion once the process has been initiated.
Pancreatic Exocrine Secretion
The exocrine pancreas delivers its secretions of digestive enzymes, fluid, and bicarbonate ions to the duodenum following ingestion of food. The pancreas is composed of both endocrine and exocrine components. The endocrine pancreas is comprised of α, β, δ, ε, and PP (F) cells, which are located in the islets of Langerhans. These specialized cells secrete the hormones insulin, glucagon, somatostatin, ghrelin, amylin, and pancreatic polypeptide into the blood, which exert endocrine and paracrine actions within the pancreas. Ninety percent of the pancreas is composed of acinar cells which secrete digestive enzymes such as trypsin, chymotrypsin, and amylase for digestion of food in the small intestine. The acinar cells are triangular in shape and arranged in clusters with the apex of the cell opening into a centrally located terminal duct. The terminal or intercalated ducts merge to form interlobular ducts, which in turn congregate to form the main pancreatic duct. The pancreatic duct delivers exocrine secretions into the duodenum. The ductal cells secrete fluid and bicarbonate ions, which neutralize acinar cell secretions, as well as the acidic gastric contents entering the duodenum (110) . The pancreas is heavily innervated by sympathetic and parasympathetic peripheral nerves and contains a dense network of blood vessels which regulate blood flow and modulate pancreatic secretion.
Pancreatic exocrine secretion is a highly integrated process mediated by neural and hormonal signals arising from the gut as well as by factors secreted by other tissues and hormones released from pancreatic islets. The secretory pathways can be stimulatory or inhibitory in nature, and represent a highly regulated system that responds to ingestive signals. The agents that modulate pancreatic exocrine secretion are discussed below (Table 1) .
Neural Mechanisms

Neural Innervation
The pancreas is innervated by parasympathetic nerve fibers, postganglionic sympathetic neurons, as well as a network of intrapancreatic nerves.
Together these nerves regulate pancreatic exocrine function by releasing neurotransmitters such as acetylcholine and neuropeptides such as VIP, GRP, serotonin, and neuropeptide Y (NPY). The pancreatic ganglia receive input from preand post-ganglionic nerve fibers and regulate exocrine and endocrine secretion.
Intrapancreatic postganglionic neurons
are activated by central input during the cephalic phase and by vagovagal responses initiated during the gastric and intestinal phases of stimulation. They stimulate enzyme and bicarbonate secretion primarily by releasing acetylcholine, which activates muscarinic receptors located on acinar and duct cells.
Vagal Innervation
The dorsal vagal complex in the brainstem is comprised of the nucleus of the solitary tract and the dorsal motor nucleus of the vagus (DMV) and exerts parasympathetic control on pancreatic secretion. Information relayed by sensory vagal afferent nerves innervating the pancreas is first processed in the nucleus of the solitary tract, which then projects onto the preganglionic motor neurons of the DMV. The DMV receives inputs from other regions of the brain such as the hypothalamus and from numerous hormones and neuropeptides through the afferent limb of the vagus nerve.
Parasympathetic preganglionic efferent vagal nerves innervating the pancreas originate primarily from the DMV and terminate in the pancreatic ganglion. Electrical and chemical stimulation of the DMV induces rapid pancreatic secretion, and this response is inhibited by vagotomy or blockade of muscarinic receptors by atropine (239) . It has been suggested that vagal cholinergic neurons mediate pancreatic secretion during low loads of intestinal stimulants whereas hormones mediate the response during high loads of intestinal stimuli (245, 304) .
CCK affects pancreatic secretion through both a direct effect on pancreatic acinar cells and an indirect effect on the vagus nerve (Figure 2) . However, the effects on the vagus nerve are complex and the firing response of neurons in the DMV complex appears to be dictated by their spatial location. In one study, neurons in the caudal region were activated, those in the rostral region were unaffected, while neurons in the intermediate region were inhibited by a direct action of CCK (238) . Although it is not fully understood, it appears that CCK's effects on the vagus nerve influences the overall pancreatic secretory response.
The exocrine pancreas is regulated directly by the vagus. Studies with muscarinic receptor knockout mice demonstrated that both M1 and M3 receptors mediate amylase release from dispersed acini. It is likely that M3 receptors are more relevant physiologically since the level of M3 receptor expression was significantly higher in acinar cells (87) and M1 receptors were found to have only a minor effect on bicarbonate secretion in conscious dogs (325) .
The vagus nerve also possesses group II metabotropic glutamate receptors that couple primarily to G i/o . These receptors are located on excitatory and inhibitory pre-synaptic terminals of pancreas-projecting DMV neurons (10) that are also activated by CCK and pancreatic polypeptide. Thus, in addition to γ-amino butyric acid, glutamate also modulates pancreatic exocrine secretion through distinct vagal neurons.
Vasoactive Intestinal Peptide VIP is a 28 amino acid neuropeptide that is found throughout the body. Immunocytochemical evidence suggests that VIP is localized in pancreatic nerve fibers and functions as a vagal neurotransmitter.
In the chick, VIP immunoreactive nerve endings are found in close proximity to acinar cells and epithelial cells of arterioles. Small clear vesicles were present in VIP-positive nerves indicating that these neurons are were also cholinergic in nature (118) . In normal human pancreas, autonomic ganglia receive an abundant supply of VIP-positive fiber plexi, and VIP-positive nerves and appeared to innervate acinar cells, ducts, and blood vessels (204) . After atropine treatment, electrical stimulation of the vagus still increased bicarbonate secretion concurrent with detection of VIP in pancreatic venous effluent suggesting that VIP release is coupled with bicarbonate secretion (70). The effects of VIP are especially prominent in the pig as perfusion of the pancreas with VIP antibodies inhibited fluid and bicarbonate secretion, and treatment of rats with a VIP antagonist reduced bicarbonate secretion concomitant with vasodepression further supporting a direct relationship (120, 337) . High and low affinity VIP receptors have been identified on pancreatic acinar membranes. The high affinity receptors are coupled to cAMP-mediated amylase release, while activation of low affinity receptors did not cause cAMP elevation or amylase release, suggesting that only high affinity receptors are important in protein secretion (23) . These effects of VIP were attenuated by somatostatin and galanin, which reduced VIP-mediated fluid and protein output (123) . One of the main functions of VIP appears to be increasing blood flow by vasodilation, and as a result its effects on pancreatic secretion independent of blood flow in the pancreas are difficult to evaluate (9, 170) .
Gastrin Releasing Peptide
Gastrin releasing peptide (GRP) is a 27 amino acid neuropeptide that is present in postganglionic vagal afferents and has been detected in neurons innervating the feline, porcine, rodent, and human pancreas (231) . Receptors responsive to GRP have been identified in rat pancreatic membranes and cancer cells where they mediate enzyme secretion (103, 146) . In the cat, GRP is present in intrapancreatic ganglia, acinar and stromal regions, and occasionally on the vasculature and ducts (51). In humans, the pattern of GRP expression was similar to that of VIP; GRP was localized on nerve fibers in proximity to pancreatic acini, capillaries, ductules, and arterial walls (298) . Several studies in different species have demonstrated that GRP modulates exocrine secretion (342) . Vagal stimulation of porcine pancreas resulted in GRP release which enhanced pancreatic exocrine secretion (157) . In isolated perfused rat pancreatic preparations, electrical field-stimulated GRP release potentiated secretin-mediated fluid and amylase secretion through a non-cholinergic pathway (264) . The effects of GRP on rat pancreatic exocrine secretion were enhanced by γ-amino butyric acid (266) . Neuromedin C, a decapeptide of GRP, also enhanced pancreatic secretion by direct action on canine acinar cells as well as indirectly by stimulating CCK release (128, 129) . However, since bombesin (GRP analog) does not stimulate pancreatic secretion in dogs, it appears that its effects may be dependent on the species being evaluated (167) . For more details on bombesin see (342) .
Other Peptide Neurotransmitters
Immunohistochemical staining has revealed that the neuropeptides listed below are present in pancreatic nerves and their functional significance and ability to regulate pancreatic secretion has been demonstrated by in vitro and/or in vivo studies.
PACAP: Pituitary adenylate cyclase-activating polypeptide (PACAP) has been identified in nerve fibers and intrapancreatic ganglion in rodents (79) . PACAP has been shown to evoke bicarbonate and enzyme secretion from the pancreas albeit with a slower time course than VIP (7, 337) . In the acinar cell line AR42J, PACAP activated phospholipase C, which led to elevation of intracellular Ca 2+ and amylase release (13) . For more details on PACAP and pancreatic secretion see (91) .
Neurotensin: Neurotensin is a 13 amino acid neuropeptide that is widely expressed in the central nervous system and is also present in pancreatic nerves. It stimulates amylase secretion and its effects are potentiated by carbachol (a cholinergic agonist), secretin, and caerulein (a CCK analog) (11, 73) . Other studies demonstrated that neurotensin stimulates bicarbonate, but not protein secretion in dogs and may act indirectly by stimulating dopamine release (134).
Substance P: Substance P is expressed in periductal nerves in the guinea pig pancreas and inhibits ductal bicarbonate secretion by modulating neurokinin 2 and 3 receptors (111, 152, 159) . It enhanced caerulein-stimulated enzyme secretion in isolated perfused pancreas as well as in anesthetized rodents (148) .
CGRP: CGRP is a 37-amino acid peptide that is present in central and peripheral neurons. The effect of CGRP on exocrine secretion is not clear and may be species specific. Interaction of CGRP with receptors on guinea pig acinar cells led to amylase release, although its effect was not as potent as VIP (295) . In rat acinar cell preparations, CGRP inhibited amylase release by a mechanism involving cholinergic (muscarinic) neural pathways (33) .
NPY: NPY, a 36 residue peptide, is expressed in intrapancreatic ganglia and nerve fibers that surround exocrine pancreatic tissue (296) . NPY inhibited CCK-and vagally-mediated amylase secretion from intact pancreas and lobules, but not from dispersed acini, suggesting that its actions were mediated by neurons innervating the exocrine pancreas (235) . Other evidence suggests that NPY plays at best only a modest role in pancreatic exocrine secretion (122) .
CCK: The presence of CCK in intrapancreatic nerves has led to the suggestion that it may serve a dual role as neurotransmitter and hormone in pancreatic secretion. However, CCK could not be detected in the venous effluent of isolated perfused porcine pancreas after vagal stimulation following a meal (120) suggesting that synaptic release of CCK does not occur within the pancreas. Therefore, the role of CCK as a neurotransmitter in pancreatic secretion merits further investigation.
Peptide Histidine Isoleucine: Peptide histidine isoleucine (PHI) is a 27 amino acid peptide with an N-terminal histidine and C-terminal isoleucine, and is derived from the same precursor molecule as VIP. It is present in pancreatic nerves and ganglia and stimulates fluid and bicarbonate secretion in a cAMP-dependent fashion (136, 296) .
Adrenergic Nerves
Compared to cholinergic stimulation, adrenergic nerves play a relatively minor role in pancreatic exocrine secretion. Catecholamine-containing nerves are found in the celiac ganglion, and extend to intrapancreatic ganglia, blood vessels, ducts, and islets (176) . Epinephrine and norepinephrine (NE) evoked amylase release from superfused rat pancreatic preparations, similar to that induced by electrical stimulation in the presence of cholinergic blockade (309) . This process is dependent on elevated intracellular Ca 2+ and inhibited by propranolol, suggesting that β-adrenergic receptors are involved (268) . Catecholamines also interact with α-adrenergic receptors expressed in pancreatic acini and inhibit amylase secretion (333) . NPY is coexpressed with NE in some nerve fibers, and stimulation of splanchnic nerves leads to the release of NPY and NE (38, 296) . Infusion of PACAP into the pancreatoduodenal artery enhanced release of NE after electrical stimulation of nerves. However, the physiological relevance of this observation is not clear (347) .
Celiac denervation reduces pancreatic secretion by ~70% while increasing blood flow by 350%. This dissonance presumably occurs by the disruption of stimulatory fibers and sympathetic fibers that maintain tonic constriction of pancreatic vessels (156) . The effect of adrenergic transmitters on pancreatic secretion has been difficult to discern due to the wide-ranging effects of norepinephrine on multiple processes including blood pressure, blood flow, neural reflexes, and release of hormones. Even though high concentrations of norepinephrine have been found in rabbit pancreatic ganglia, ducts, and blood vessels, its effects are controversial (348) . Norepinephrine has been reported to stimulate, inhibit, or have no effect on pancreatic secretion (12, 41, 60, 84, 176, 183, 312) . Unfortunately α-and β-adrenergic receptor agonists and antagonists have not provided information that could be used to delineate mechanisms important in adrenergic regulation of pancreatic secretion (40, 61).
Dopamine
Dopamine was detected in pancreatic ducts and ampullae and dopamine β-hydroxylase (DBH) -positive fibers were identified along the vasculature, ducts, and ganglia suggesting it may play some role in pancreatic secretion (198, 348) . There is conflicting evidence regarding the role of dopamine in pancreatic secretion. Dopamine stimulates pancreatic secretion in anesthetized dogs and rats although the effect is negligible in conscious animals (17, 55, 60, 84, 131, 135) . Other data suggest that the secretory response to dopamine differs between dogs, cats, rabbits and rats, and species specific effects must be taken into consideration when evaluating its effects (109) .
Serotonin
Like dopamine, serotonin is present in pancreatic ducts and ampullae. Autoradiography of tissue sections after tritiated serotonin uptake demonstrated the presence of serotonergic innervation of blood vessels, but not exocrine parenchyma in rats, suggesting a limited role in pancreatic secretion (158, 348) . However, phenylbiguanide, a 5-HT3 receptor agonist, activated preganglionic neurons located in the caudal DMV, inhibited those in the intermediate DMV, and had no effect on rostral DMV neurons, suggesting complex spatial regulation of pancreatic vagal neurons by serotonin (238) . Intraduodenal infusion of melatonin (a serotonin derivative) increased pancreatic amylase secretion, while pretreatment with 5-HT2 serotonin antagonist ketanserin or the 5-HT3 antagonist MDL72222 decreased amylase release. Serotonin-induced amylase release was blocked by bilateral vagotomy supporting a role for serotonergic mechanisms on exocrine secretion (243) .
Nitric Oxide
Nitric oxide (NO) is a gaseous signaling molecule that is synthesized by NO synthase (NOS) from Larginine in the presence of nicotinamide adenine dinucleotide hydrogen phosphate (NADPH). It is a potent vasodilator and modulates secretory activity as well as pancreatic blood flow in the pancreas (44) . Because it is not practical to directly measure NO in biological tissues, the presence of NO has been identified by expression of NOS or histochemistry of NADPH diaphorase (NADPH-d), since NOS and NADPH-d colocalize in neurons of the peripheral and central nervous systems. The actions of NO in tissues have been identified by the use of NO donors, NOS inhibitors, and agents that inactivate (e.g. superoxide-generating compounds) or stabilize NO (e.g., superoxide dismutase). Unlike ligands that signal through cell surface receptors, NO penetrates cells and activates guanylate cyclase to generate the second messenger cGMP (345) .
Immunostaining of pancreas from a wide range of mammals (mouse, rat, hamster, guinea-pig, cat and man) indicates that NOS is expressed in the cell bodies of intrapancreatic ganglia, interlobular nerve fibers, and along blood vessels. VIP is sometimes co-expressed with NOS in ganglia and nerve fibers. These studies suggest that NO is important in pancreatic exocrine secretion (66). In newborn guinea pig, nitrergic neurons were present primarily in the head and body of the pancreas, along blood vessels, the main pancreatic duct, and in association with pancreatic acini (195) . These nerves also immunostained with antibodies against NPY, VIP, and DBH indicating complex co-regulation of pancreatic secretion by various neurotransmitters.
In rat pancreas, the NO donor sodium nitroprusside and cGMP analog 8-bromo cGMP, inhibited basal and vagal amylase secretion through a Ca 2+ -dependent mechanism (68, 346).
The G protein-coupled receptor, proteaseactivated receptor-2 (PAR-2) modulates NOmediated amylase release in mice, and inhibition of NOS abolished PAR-2 mediated amylase release suggesting that the effects of NO may be mediated by neuronal release of a PAR-2 agonist. Ablation of sensory nerves by capsaicin did not affect PAR-2 mediated amylase release, suggesting that TRPV1-expressing sensory vagal fibers are not involved in this pathway (150) . Analysis of the effects of NO on pancreatic secretions in pigs support the findings that NO is essential for pancreatic fluid and amylase secretion mediated by the vagus nerve (124) . Thus, in addition to maintaining the vascular tone, nitrergic nerves play an important role in pancreatic fluid and amylase release.
Stimulatory Hormones
Cholecystokinin CCK is released from specialized enteroendocrine cells (I cells) located mainly in the upper small intestine. The major stimulants of CCK release are dietary fats and proteins. In the rat, intraluminal proteases via an active feedback system participate in the release of a putative intestinal CCK releasing factor (e.g., LCRF) which in turn causes CCK secretion (115, 314) . Various molecular forms of CCK, ranging in size from CCK-8 [CCK-(26-33)-NH 2 ] to CCK-58, have been described in dogs, rats, and humans (65, 69, 329). CCK-58, was determined to be the predominant peptide in dogs and humans, and the only form detected in rats after employing CCK isolation techniques that prevented degradation of CCK in blood (272) . The actions of CCK-8 and CCK-58 appear to be functionally identical suggesting that CCK-8 retains the biological activity ascribed to this hormone (49) .
CCK is post-translationally modified and has an amidated C-terminus. A sulfated tyrosine residue in CCK-8 is important for its biological actions including exocrine secretion (141, 285 CCK mediates its hormonal effects through two G-coupled protein receptors, CCK-1 and CCK-2, previously known as CCK-A and CCK-B, respectively. The contribution of these receptors to pancreatic secretion has been evaluated in order to delineate the molecular mechanisms of CCK action. CCK receptors have been proposed to exist in two states, a high affinity (picomolar) but low capacity state, and a low affinity (nanomolar) but high capacity state (322, 332) . Autoradiography of pancreatic membranes incubated with radioiodinated CCK-8 demonstrated that CCK-1 receptors are highly expressed in rat pancreas, while CCK-2 receptors are less abundant. CCK-1 receptors appear to modulate pancreatic secretion as oral administration of loxiglumide, a potent CCK-1 receptor antagonist, reduces protein and fluid output in rats (132) . Similarly, caerulein-induced pancreatic amylase release was blocked by CCK-1 receptor antagonists (99) . CCK-8 also did not induce amylase release in CCK-1 receptor knockout mice confirming that CCK-1 receptors are critical for CCK-mediated protein secretion (172) . Since bicarbonate secretion was not observed from dispersed acinar cells this effect is not believed to be regulated by CCK receptors (320) . Pancreatic responses in CCK-2 receptor knockout mice were similar to wild type mice suggesting that CCK-2 is not important for amylase release, although it may be involved in augmenting vascular flow (99, 230) . In pigs, where a majority of receptors are of the CCK-2 subtype, acinar cells demonstrated a low responsivity to CCK and did not secrete amylase in response to caerulein or a CCK-1 agonist (233) . In humans, the actions of CCK on pancreatic secretion have been variously reported. Infusion of CCK, caerulein, and secretin in the presence of amino acids substantially increased output of fluid, bicarbonate, and enzyme (162, 318) . Similar to porcine pancreas, CCK-2 is the major CCK receptor subtype expressed in human pancreas, although interestingly CCK-1 receptor antagonists are able to inhibit amylase secretion (3, 270, 321) . In dispersed human acini which responded to carbamylcholine and neuromedin C, CCK did not stimulate amylase release presumably because of a paucity of cellular membrane receptors. It has been proposed that the effects of CCK on human pancreatic secretion are mediated through CCK-1 receptors on nerves which innervate the pancreas (142, 229) . However, recent data demonstrated that application of physiologic concentrations of CCK-8 and CCK-58 to human acinar cells produced intracellular Ca 2+ oscillations and normal exocytosis of pancreatic enzyme, suggesting that functional CCK receptors are expressed on human pancreas (237) . Thus, it appears that CCK receptors are expressed on acinar cells of both human and rodent pancreas, and the differences between the two may not be as great as previously predicted.
Recently it was shown that rat and human pancreatic stellate cells express CCK receptors and secrete acetylcholine in response to CCK stimulation. This source of acetylcholine was sufficient to stimulate amylase release from acinar cells. Pancreatic stellate cells may represent a previously unrecognized intrapancreatic pathway regulating CCK-induced pancreatic exocrine secretion (269) .
Several hormones and neuropeptides regulate CCK-mediated exocrine secretion. Locally, insulin has been shown to influence exocrine secretion. Intra-arterial infusion of canine pancreas with antiinsulin antibodies, prevented CCK stimulation as well as secretin-mediated protein and fluid secretion from canine pancreas (178) . Secretin potentiated, as well as attenuated, CCK-mediated amylase secretion by the inositol signaling pathway while VIP enhanced CCK-mediated enzyme secretion (35, 36) . Peptide YY (PYY), PP, and somatostatin also inhibited CCK-mediated protein secretion and their effects are discussed later in this review.
The mechanism of CCK-induced amylase secretion, involves transient elevation in intracellular Ca 2+ (257) . It also requires phospholipase C activation and generation of second messengers inositol trisphosphate and diacylglycerol (259) . In some instances, CCK activates secretion by elevation of cAMP, as 8-bromo-cAMP and a phosphodiesterase inhibitor augmented CCK-mediated amylase release (35) . Heterotrimeric G proteins Gα 13 and Gα q through downstream interactions with small GTP binding proteins RhoA and Rac1 regulate actin cytoskeleton reorganization which is required for exocytosis (280, 343) .
Secretin
Secretin is a 27 amino acid hormone released by S cells of the small intestine (340) . Secretin release is stimulated during the intestinal phase upon entry of gastric acid and ingested fatty acids into the duodenum (71). It augments fluid and bicarbonate secretion and is one of the most potent stimulators of pancreatic secretion (43) . Examination of pancreatic ultrastructure shortly after secretin injection revealed that fluid is secreted by duct as well as acinar cells (26) .
Large increases in pancreatic fluid and bicarbonate secretion have been demonstrated with secretin infusions as low as 1-2.8 pmol/kg•hr (19, 102, 290, 350) . In humans, bolus injections of secretin as low as 0.125 pmol/kg stimulated fluid and bicarbonate secretion (145, 289) . Although secretin is believed to be the single most powerful stimulator of pancreatic bicarbonate secretion, infusion of exogenous secretin equivalent to postprandial blood levels only produced 10% of the maximal pancreatic bicarbonate secretory response suggesting that other hormones and neurotransmitters play important roles in postprandial pancreatic bicarbonate secretion in humans (289, 290) . Secretin receptors have been localized in acinar and duct cells in the rat pancreas (330) . Secretin stimulates the release of fluid and bicarbonate, and to a lesser extent, protein from acinar cells by a cholinergic mechanism. Perfusion of acetic and lactic acids in the duodenum of anesthetized rats increased fluid and protein output from the pancreas concomitant with elevation of plasma secretin levels. In addition, treatment of rats with atropine decreased plasma secretin levels and inhibited fluid (but not protein) secretion, indicating that only fluid secretion is dependent on cholinergic input (286) . Electrical field stimulation of isolated perfused rat pancreas demonstrated that secretin-mediated exocrine secretion was sensitive to tetrodotoxin and atropine blockade, further suggesting cholinergic regulation. Nicotinic acetylcholine receptors are not involved in this mechanism as hexamethonium did not exert an inhibitory effect on pancreatic secretion (265) .
Both cAMP-dependent and independent pathways contribute to secretin-mediated exocrine secretion. Interaction of secretin with its receptor induced a 3-4 fold increase in adenylate cyclase activity which was abolished in the presence of secretin antagonists (212). Secretin did not stimulate pancreatic fluid release or elevate acinar cell cAMP levels in secretin receptor knockout mice (287) . Exocrine protein secretion by secretin was associated with phospholipase C activation in one report (327) . At secretin concentrations >10 -8 M, inositol trisphosphate and diacylglycerol were generated in acinar cells, which caused release of Ca 2+ from intracellular stores and activated protein kinase C. However, not all investigators have observed this effect.
Several hormones and peptides modulate the effects of secretin on pancreatic secretion. CCK augmented secretin-induced pancreatic fluid and protein output by stimulating acetylcholine release and this effect was blocked by atropine or by dispersion of acini (6, 313) . Venous drainage from pancreatic islets bathes the exocrine pancreas with high concentrations of islet hormones. Several of these hormones have potent effects on pancreatic secretion. Insulin enhances secretinmediated fluid and protein secretion through an ouabain-sensitive Na + ,K + -ATPase while glucagon inhibits secretin-stimulated release of fluid and protein (108) . Addition of anti-somatostatin antibodies increased secretion from perfused rat pancreas implying that somatostatin inhibits secretin-induced fluid and enzyme secretion (108, 265) .
Atrial Natriuretic Factor and C-Natriuretic Peptide
Atrial natriuretic factor (ANF) is a peptide hormone that is secreted by atrial stretch and regulates blood pressure and volume by inhibiting reabsorption of sodium by the kidney (334) . Immunochemical studies showed that ANF is present in acinar cells. Early studies suggested that ANF did not influence protein or fluid secretion. However, incubation of rat acini with ANF caused a dose-dependent elevation of cellular cGMP (112) showing that guanylate cyclase receptors transduce ANF signaling (199) . Injection of human ANF in dogs induced bicarbonate but not sodium or protein secretion (249) . ANF also stimulates pancreatic natriuretic peptide receptor-C (NPR-C)-mediated phosphoinositide-dependent pathway in rats, causing the release of fluid and protein (284) . NPR-C is a non-guanylyl cyclase receptor and is coupled to adenylyl cyclase inhibition or phospholipase C activation through G i proteins. ANF attenuated secretin-and VIP-induced elevation of intracellular cAMP and this effect was blocked by inhibitors of protein kinase C and phospholipaseC (283) . Along with elevating intracellular cAMP, secretin mediates the efflux of cAMP from intact pancreas and acinar cells. ANF augmented secretin-induced cAMP efflux and caused the rapid elimination of cAMP from cells. The multidrug resistance protein 4 (MRP4) has been reported to play a role in the extrusion of cAMP in many cellular systems. MRP4 is also expressed in the pancreas and genetic knockdown of MRP4 expression reduced intracellular cAMP levels in acinar cells by ANF and an NPR-C dependent mechanism (277).
C-natriuretic peptide (CNP) is structurally similar to ANF and is expressed in the CNS and gastrointestinal tract. CNP increases pancreatic protein, chloride, and fluid secretion (without influencing bicarbonate output) suggesting that it acts on acinar rather than duct cells. Truncal vagotomy or perivagal application of capsaicin or hexamethonium attenuated chloride secretion, demonstrating that the effect of CNP is modulated by the parasympathetic nervous system (282) . At low concentrations, CNP induced protein secretion by activation of NPR-C. Similar to ANF, CNP-induced amylase release was inhibited by PLC and PKC inhibitors. CNP also elevated intracellular cGMP and reduced cAMP concentrations suggesting that CNP can interact directly with receptors located on pancreatic acini (281) .
Insulin
Insulin modulates pancreatic exocrine function and insulin receptors are present in high density on the basolateral surfaces of acinar cells (21) . Insulin increases pancreatic enzyme synthesis and secretion and its effects are enhanced by CCK and secretin (4, 154, 179, 181, 205) . Since CCK induces insulin release in the presence of glucose and amino acids, it is possible that these two hormones act in conjunction on exocrine stimulation following food intake (191, 285) .
Limited data suggest that insulin regulates exocrine secretion by potentiation of ouabainsensitive Na + ,K + -ATPase and by vagal cholinergic input (108, 205, 267) . The action of insulin on exocrine secretion is modulated by PP which exerts an inhibitory effect on pancreatic secretion (263) . Since galanin, pancreastatin, and somatostatin are known to inhibit insulin secretion, it is possible that these peptides also regulate insulin-mediated amylase release (16, 180, 224) .
Bombesin
Bombesin is a 14 amino acid peptide homolog of GRP and neuromedin B and has the ability to suppress appetite (342) . The effects of bombesin on pancreatic exocrine secretion appear to vary based on the species. In pigs, administration of bombesin alone or in combination with secretin induced protein but not fluid secretion (185) . In guinea pigs, bombesin was very effective in inducing bicarbonate release from interlobular ducts, and this effect was blocked by a GRP receptor antagonist (318) . Administration of bombesin to rats resulted in pancreatic hypertrophy with increased pancreatic weight, protein, RNA, and enzyme content and this effect was not regulated by CCK or secretin (184, 316) .
Melatonin
Melatonin is a lipophilic hormone produced by the pineal gland as well as by certain neuroendocrine cells located in the gastrointestinal tract.
Melatonin receptors are present on acinar cells and melatonin protects the pancreas against caerulein-induced acute pancreatitis (140) . Initial studies showed that melatonin induced pancreatic amylase release which was mediated by CCK, vagal sensory nerves, and melatonin type 2 receptors. However, melatonin did not appear to have a direct effect on pancreatic acinar cells (138, 139, 182, 244) . The extent and importance of melatonin-induced pancreatic secretion is not well understood and merits further investigation.
Amylin
Amylin is a 37 amino acid hormone that is cosecreted along with insulin from pancreatic β-cells in response to nutrients. Amylin stimulates CCKindependent pancreatic secretion in rats, and this effect is blocked by proton pump inhibitors and atropine, perhaps due to inhibition of somatostatin release (80) . Amylin was also shown to stimulate protein secretion from pancreatic AR42J cells by a mechanism involving activation of GPCRs and release of Ca 2+ from intracellular stores (130) .
Others investigations have suggested that amylin has no effect on pancreatic exocrine secretion from isolated perfused pancreas, acinar preparations, or AR42J cells (72, 153, 351) . Hence the effects of amylin on exocrine secretion remain unresolved.
Histamine
The amino acid histamine is a potential mediator of pancreatic exocrine secretion, although it may have a gender-dependent role (308) . Activation of H1 receptors and inhibition of H2 receptors in the rabbit pancreas led to an increase in fluid and protein secretion suggesting differential action based on regulation and coupling of the two receptors (262) . The effect of histamine on pancreatic secretion is considered to be minor at best under normal physiological conditions.
Inhibitory Hormones
Peptide YY and Pancreatic Peptide
The NPY family of peptides consists of three hormones: NPY, PYY, and PP (90, 341) . All three peptides contain 36 residues several of which are tyrosines and share a tertiary structural motif known as the PP fold. The N-terminal amino acids of PYY and NPY can be cleaved by peptidases to generate truncated forms, PYY and NPY , which are biologically active. NPY has been localized to sympathetic pancreatic nerves and its role has been discussed previously in this review (38) . In islets, PYY is coexpressed with glucagon in α cells, whereas PP is secreted postprandially by F cells of the islets of Langerhans. In certain species, PP immunopositive cells are also present in the exocrine pancreas and some of these PP cells also express PYY (67). These three hormones exert their effects through a family of five GPCRs denoted Y1-5. NPY and PYY possess similar affinity for Y1, Y2 and Y5, PYY interacts preferentially with Y2, whereas PP is the preferred ligand for Y4 (126) .
PYY levels in blood are elevated postprandially and following instillation of fatty acids into the distal small intestine (203) . Physiologically relevant concentrations of PYY in the circulation inhibit both meal-and hormone-stimulated pancreatic secretion (260, 261, 323 PP secretion is also stimulated by ingesting a meal and can be reproduced by intraduodenal infusion of acid, aromatic amino acids, or fatty acids (20, 45, 151, 292, 324) . Like PYY, PP attenuated secretin-and CCK-mediated exocrine secretion in dogs independent of cholinergic blockade (56, 57, 161). PP decreased secretinand secretin plus CCK-mediated amylase release in dispersed acini, suggesting that PP can act directly on acinar cells (144) . However, although bovine and rat PP inhibited CCK-stimulated protein secretion in vivo, both peptides were ineffective in vitro, and binding of bovine PP to rat acinar cells or lobules was not observed (197) . In humans, unlike dogs, infusion of PP decreased pancreatic protein output, but did not influence bicarbonate secretion suggesting species-specific differences in PP action (165) . However, unlike PYY, PP does not affect pancreatic blood flow and therefore inhibits exocrine secretion by a different mechanism (56, 57, 161).
Somatostatin
Somatostatin is composed of 14 or 28 amino acids and is produced by δ cells of pancreatic islets. It is also secreted by certain intestinal cells and by the hypothalamus. It is released into the blood after a meal but functions primarily through a paracrine mechanism. It has broad inhibitory actions on the release of several hormones and their target organs.
Somatostatin and its analogs inhibited secretinand CCK-induced protein secretion in a dosedependent fashion. Low doses of somatostatin exerted a greater inhibitory effect on CCKstimulated pancreatic secretion compared to secretin-stimulated secretion (180, 192, 300, 301) . Secretin-mediated activation of slowlyactivating voltage-dependent K + channels (present on the basolateral surface of pancreatic acini) resulted in cAMP generation and secretion of chloride ions. Addition of somatostatin to acini, decreased intracellular cAMP production as well as secretin-mediated enhancement of K + current suggesting that somatostatin regulates exocrine secretion through this pathway (177) . Additionally, somatostatin inhibited Ca 2+ -dependent and cAMPstimulated amylase release by inhibiting exocytosis through a G i protein-dependent mechanism (250).
Somatostatin also inhibits exocrine secretion via a neural mechanism. Based on atropine, hexamethonium, and tetrodotoxin sensitivities it appears that peptidergic but not cholinergic and nicotinic acetylcholine receptors present on sympathetic and parasympathetic ganglia mediate somatostatin action (236) . Somatostatin-mediated inhibition of secretin-stimulated fluid and protein secretion was not influenced by denervation, suggesting that extrapancreatic nerves are not involved. Bethanechol, a muscarinic receptor agonist, reversed the inhibitory effects of somatostatin, indicating that its actions are mediated primarily by intrapancreatic cholinergic neurons (174) .
The mechanisms by which somatostatin inhibits pancreatic secretion are not completely understood. However, it is believed that somatostatin has an inhibitory effect on the release of hormones and neurotransmitters that normally stimulate pancreatic secretion.
Galanin
Galanin is a 29 amino acid peptide that plays diverse roles including inhibition of insulin, somatostatin, and PP secretion from the pancreas (14) . It is found in the secretory granules of central and peripheral neurons suggesting that it functions as a neurotransmitter. Galanin immunoreactivity was present in nerve fibers surrounding acini, ductules, and blood vessels, with 73% of fibers being dual positive for galanin and VIP (299) . Galanin receptor 3 mRNA is present in acinar cells indicating that galanin can act directly on acini (15) . Consistent with this finding, galanin inhibited CCK-and carbacholstimulated amylase release from acinar cells (5) . Galanin inhibited the sustained phase of amylase release stimulated by carbachol, suggesting that it attenuates cholinergic action possibly by a mechanism that involves pertussis toxin-sensitive G i proteins (16, 77, 114, 147) . Extrapancreatic nerves are not involved in its action since galanin inhibited food-, secretin-and CCK-mediated fluid release, as well as food-and CCK-mediated protein release in both innervated and denervated dogs (31) .
Pancreastatin
Pancreastatin is derived from the cleavage of chromogranin A and is expressed in many neuroendocrine tissues. It has been localized to duct cells of the exocrine pancreas and its numerous roles include inhibition of pancreatic exocrine secretion (1). Initial studies showed that pancreastatin inhibited postprandial fluid and protein secretion in rats with bile-pancreatic juice diversion. No effect was observed on basal secretion, secretin-stimulated secretion in conscious rats, or CCK-stimulated secretion from dispersed acini. However, pancreastatin inhibited CCK-stimulated pancreatic secretion in conscious rats although it did not influence plasma CCK levels. These results suggest that pancreastatin does not have a direct effect on acinar cells, but may regulate the intestinal phase of pancreatic secretion (81, 222, 224, 335) . Pancreastatin inhibited caerulein-induced blood flow in the exocrine pancreas raising the possibility that its inhibitory effects are derived from its role in regulating pancreatic blood flow (220) .
Glucagon
Glucagon is released from the endocrine pancreas after ingestion of a meal ( (29) . Early investigations suggested that glucagon inhibited secretin-or secretin-and CCK-stimulated pancreatic protein but not bicarbonate secretion (47, 221) . However other studies have demonstrated that glucagon inhibits postprandial protein and bicarbonate secretion (78, 106, 307) . The effect of glucagon on isolated pancreatic lobules and acini appears to be direct and stimulatory, instead of inhibitory, suggesting complex action at the cellular versus physiological levels (2, 127, 258, 310) . The experimentally observed effects of glucagon on exocrine secretion are inconclusive and merit further investigation.
Ghrelin
Ghrelin is a 28 amino acid orexigenic hormone released by gastric endocrine cells under fasting conditions. Ghrelin stimulates acid secretion by oxyntic cells in the stomach, and plasma levels of ghrelin rise immediately before a meal suggesting a role in modulating ingestive behavior. In the pancreas both ghrelin and its receptor have been identified in acini by evaluation of protein and mRNA expression. Ghrelin expression was not altered by gastric acid inhibition, acute pancreatitis, or food deprivation although its receptor was upregulated by gastric acid inhibition and downregulated during acute pancreatitis (175) . Experimentally, ghrelin did not affect basal or CCK-stimulated amylase release from dispersed acini. However, ghrelin inhibited CCKstimulated protein secretion in normal and vagotomized rats and amylase secretion from lobules exposed to depolarizing potassium concentrations, suggesting that it modulates intrapancreatic neurons (353) .
Leptin
Leptin is a 16 kDa orexigenic peptide that is secreted by adipocytes and regulates energy homeostasis by reducing food intake while increasing energy expenditure. In the pancreas, intravenous or intraperitoneal administration of leptin reduced basal and CCK-stimulated protein output in vivo. This effect was attenuated by CCK-1 receptor blockade, vagotomy, and capsaicin pretreatment suggesting that it inhibited pancreatic exocrine secretion through a CCKdependent vagal pathway. Leptin had no effect on dispersed acini in vitro, further supporting a neural mechanism of action (137, 206) . In contrast, intraduodenal infusion of leptin in fasted rats augmented pancreatic protein output possibly by elevating plasma CCK levels leading to activation of sensory neurons (242) .
Adrenomedullin
Adrenomedullin is colocalized with PP in F cells of pancreatic islets and inhibits insulin (196) . It interacts directly with acinar cells and inhibits CCK-stimulated pancreatic amylase release possibly by modulating intracellular Ca 2+ levels and exocytosis (328) . The mechanism of adrenomedullin action is not well understood.
Conclusion
Pancreatic secretion is a complex process that is initiated by the sight and smell of food and progresses until food enters the duodenum. At each level of food digestion, this process is regulated by a various stimuli which affect neuronal and hormonal pathways. These pathways are both stimulatory and inhibitory and optimize the release of enzymes, bicarbonate, and fluid. 
